-
Most Popular
Search Results
240 results for fsa
MSA Stock Earnings: MSA Safety Beats EPS, Beats Revenue for Q2 2024
MSA stock results show that MSA Safety beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
3 Massively Undervalued Dividend Stocks With a Yield of Over 5%
These are the top undervalued dividend stocks to buy — they represent fundamentally strong ideas with robust cash flows.
7 Undervalued Stocks to Buy With a Dividend Yield of Over 7%
These are the undervalued stocks to buy as they represent companies with strong fundamentals and a robust dividend yield
3 Drone Delivery Stocks Ready for Takeoff
Drone delivery stocks are poised for takeoff, promising faster, safer and more efficient delivery solutions, reshaping logistics and retail.
3 Flying Car Stocks That Could Grow Your Wealth
Explore flying car stocks with the potential to grow investors’ wealth as the industry progresses toward commercial air taxi services.
FSV Stock Earnings: FirstService Beats EPS, Beats Revenue for Q2 2024
FSV stock results show that FirstService beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
FSS Stock Earnings: Federal Signal Beats EPS, Beats Revenue for Q2 2024
FSS stock results show that Federal Signal beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
SKX Stock Earnings: Skechers USA Misses EPS, Misses Revenue for Q2 2024
SKX stock results show that Skechers USA missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
FIX Stock Earnings: Comfort Systems USA Beats EPS, Beats Revenue for Q2 2024
FIX stock results show that Comfort Systems USA beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Why Is Agenus (AGEN) Stock Down 55% Today?
Agenus stock is down on Thursday after the company provided AGEN investors with an update on a Phase 2 clinical trial meeting.
Biotech Stock Laboratory: Try a Small Experiment With Kazia Therapeutics
Kazia Therapeutics stock is a fast mover in both directions and has long-term rally potential after Kazia Therapeutics’ clinical victory.
TSLA Stock Outlook: Why Tesla Is a Solid Buying Opportunity Now
Discover why Tesla stock is soaring following its Q2 performance, production boosts and strategic investments driving growth in 2024.
Why Is Salarius Pharmaceuticals (SLRX) Stock Up 90% Today?
While Salarius Pharmaceuticals encountered a hiccup in its genomics research, the possibility of new funding may have lifted SLRX stock.
3 Undervalued Biotech Stocks With Breakout Potential
Invest in these three undervalued biotech stocks with double-digit upside ahead driven by cutting-edge healthcare advancements
3 Companies Gearing Up for a Stock Split
These stock split candidates could follow the route of Nvidia, Walmart and Chipotle Mexican Green in the near future.
Two Magnificent Seven Earnings Are In… Who Wins the Gold?
in today’s Market 360, we’ll review and preview the Magnificent Seven results today. And then, I’ll share another area of the market we should watch…
Social Security Underpayments Release: What to Know as $901 Million Hits Beneficiaries
Social Security underpayments are a hot topic on Thursday as the SSA confirms its catching up on late or missed payments to beneficiaries.
Alnylam Stock Is a Blockbuster Biopharma In the Making
Alnylam stock could significantly pad its initial gains if vutrisiran gains expedited approval to hit the market.
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Dexcom’s Stelo faces an uncertain future thanks to drugs like Wegovy and a competing Abbott Labs product. DXCM stock is down 40% today.
Donald Trump Says He Loves Elon Musk. Tesla Stock Is Now Climbing Higher
Musk’s endorsement of Trump may help its prospects, but TSLA stock investors will be looking more at its earnings, due out July 23.
3 Oil & Gas Stocks to Buy Now: Q3 Edition
These are the oil & gas stocks to buy now as they are positioned to benefit from higher oil prices and have strong fundamentals.
3 Fintech Stocks to Buy at 52-Week Lows in July
Several fintech stocks hitting 52-week lows in July offer significant growth potential. Here are three fintech stocks to buy this month.
LGVN Stock Alert: Longeveron Pops 18% on FDA Fast-Track Designation
Longeveron stock is up on Wednesday as LGVN investors react to Lomecel-B being granted fast-track designation by the FDA.
Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?
Little-known firm Sangamo Therapeutics is surging today, with SGMO stock up more than 40% on promising late-stage trial results.
1 – 10 of 240 results
